CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- S-3 Offering Registration Statement
- 4 Gift Chief Scientific Officer gave 15,000 shares (gift)
- 4 Shares withheld for taxes INTERIM CEO gave up 68,343 shares (to pay taxes)
- D Other Notice of Sales of Unregistered Securities
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes INTERIM CEO gave up 2,721 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 666,666 shares at $2.25 ($1,499,999)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,721 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
Page 7 of 44 · 872 filings